Charles E. Geyer
Impact in
- Cancer Research top 0.05%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.05%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
-
- Breast Cancer Treatment Studies 91
- Oncology 146
- HER2/EGFR in Cancer Research 85
- Cancer Treatment and Pharmacology 68
- Colorectal Cancer Treatments and Studies 14
- Co-authors
- Norman WolmarkEleftherios P. MamounasSoonmyung PaikD. Lawrence WickerhamJoseph P. CostantinoPriya RastogiStewart AndersonJong‐Hyeon Jeong
- Journals
- Journal of Clinical Oncology (77 papers)Cancer Research (14 papers)Annals of Oncology (9 papers)Breast Cancer Research and Treatment (8 papers)Clinical Cancer Research (7 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Charles E. Geyer
178 papers receiving 15.8k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Cancer Research 8.6k
- Oncology 11.3k
- Pathology and Forensic Medicine 2.9k
- Radiology, Nuclear Medicine and Imaging 3.1k
- Pulmonary and Respiratory Medicine 3.2k
Countries citing papers authored by Charles E. Geyer
This map shows the geographic impact of Charles E. Geyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Geyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Geyer more than expected).
Fields of papers citing papers by Charles E. Geyer
This network shows the impact of papers produced by Charles E. Geyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Geyer. The network helps show where Charles E. Geyer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles E. Geyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 22 | |
| 9 | 2020 | 80 | |
| 10 | 2019 | 24 | |
| 11 | 2015 | 33 | |
| 12 | 2013 | 64 | |
| 13 | 2013 | 119 | |
| 14 | Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27 Hit paper breakdown → | 2012 | 394 |
| 15 | 2010 | 10 | |
| 16 | 2010 | 230 | |
| 17 | 2010 | 114 | |
| 18 | 2008 | 134 | |
| 19 | 2008 | 33 | |
| 20 | Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31 Hit paper breakdown → | 2005 | 568 |
About Charles E. Geyer
Charles E. Geyer is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 183 papers that have together received 16.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (91 papers), HER2/EGFR in Cancer Research (85 papers), Cancer Treatment and Pharmacology (68 papers), Advanced Breast Cancer Therapies (41 papers), Estrogen and related hormone effects (27 papers), Monoclonal and Polyclonal Antibodies Research (20 papers), Breast Lesions and Carcinomas (18 papers) and Colorectal Cancer Treatments and Studies (14 papers). The work is most often cited by research in Cancer Research (8.6k citations), Oncology (11.3k citations), Pathology and Forensic Medicine (2.9k citations), Radiology, Nuclear Medicine and Imaging (3.1k citations) and Pulmonary and Respiratory Medicine (3.2k citations). Charles E. Geyer has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Norman Wolmark, Eleftherios P. Mamounas, Soonmyung Paik, D. Lawrence Wickerham, Joseph P. Costantino, Priya Rastogi, Stewart Anderson, Jong‐Hyeon Jeong, Gong Tang and Sandra M. Swain. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Breast Cancer Research and Treatment and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.